Tower Research Capital (TRC)’s Soligenix SNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,055
Closed -$5.86K 5556
2025
Q3
$5.86K Buy
5,055
+3,668
+264% +$8.43K ﹤0.01% 4193
2025
Q2
$1.82K Buy
+1,387
New +$2.62K ﹤0.01% 4739
2024
Q4
Sell
-930
Closed -$3.69K 5977
2024
Q3
$3.69K Sell
930
-2,742
-75% -$11.5K ﹤0.01% 4797
2024
Q2
$9.47K Buy
3,672
+3,237
+744% +$18.7K ﹤0.01% 4245
2024
Q1
$4.18K Buy
435
+12
+3% +$135 ﹤0.01% 4718
2023
Q4
$5.13K Sell
423
-8
-2% -$70 ﹤0.01% 4877
2023
Q3
$3.84K Hold
431
﹤0.01% 4947
2023
Q2
$4.85K Sell
431
-316
-42% -$5.49K ﹤0.01% 4893
2023
Q1
$24K Buy
747
+667
+834% +$51.2K ﹤0.01% 3255
2022
Q4
$9K Buy
80
+3
+4% +$433 ﹤0.01% 4263
2022
Q3
$8K Buy
77
+21
+38% +$3.69K ﹤0.01% 4808
2022
Q2
$8K Buy
56
+20
+56% +$2.77K ﹤0.01% 4707
2022
Q1
$6K Buy
+36
New +$5.79K ﹤0.01% 4924
2021
Q3
Sell
-5
Closed -$1K 6139
2021
Q2
$1K Hold
5
﹤0.01% 5255
2021
Q1
$2K Sell
5
-67
-93% -$26.6K ﹤0.01% 5047
2020
Q4
$22K Buy
72
+19
+36% +$8.71K ﹤0.01% 3813
2020
Q3
$23K Buy
53
+41
+342% +$20.2K ﹤0.01% 3818
2020
Q2
$6K Buy
+12
New +$4.95K ﹤0.01% 4230

Other funds holding SNGX

Tower Research Capital (TRC)'s SNGX Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Soligenix (SNGX) in Q4 2025, closing a stake of 5,055 shares — an estimated $5.86K sold.

Tower Research Capital (TRC) first reported a position in SNGX in Q2 2020 and held it in 18 quarters. The position peaked at $24K in Q1 2023. 19 funds tracked by Wall St. Rank hold SNGX as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining Soligenix position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,055 Soligenix shares in Q4 2025, an estimated $5.86K.
  • Tower Research Capital (TRC) first reported a position in Soligenix in Q2 2020 and held it in 18 quarters.
  • Tower Research Capital (TRC)'s Soligenix position peaked at $24K in Q1 2023.
  • 19 funds tracked by Wall St. Rank held Soligenix as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.